More than 25 million bottles of sunscreen and after-sun products have been recalled after testing turned up benzene, a chemical linked to cancer, in a wide range of popular brands. According to Consumer Reports, the contamination has touched at least 15 brands, with Neutrogena, Aveeno and Coppertone among those that voluntarily pulled affected lots from shelves.
The recall is unsettling precisely because sunscreen is a product people are urged to use liberally and often, including on children, to prevent skin cancer. Finding a carcinogen in a product marketed as a health safeguard creates an uncomfortable paradox, and it has drawn attention to how contaminants can slip into consumer goods during manufacturing rather than through any intended ingredient.
How the contamination was found
The independent testing pharmacy Valisure flagged benzene in 78 different sunscreen and after-sun care products during batch testing. In some of the affected Aveeno and Neutrogena lots, benzene measured between 11.2 and 23.6 parts per million — roughly five to twelve times the level the U.S. Food and Drug Administration says should be the ceiling for products where the chemical cannot be avoided.
Independent batch testing has become an increasingly important backstop in consumer safety, catching problems that neither manufacturers nor regulators surface on their own. Because benzene is not a deliberate ingredient in sunscreen, its presence points to contamination somewhere in the supply chain — in raw materials, solvents or processing — which is why the problem shows up in specific lots and brands rather than across the category as a whole.
Why benzene is the concern
Benzene is a well-documented human carcinogen. Long-term exposure through inhalation, ingestion or skin absorption has been tied to leukemia and other blood disorders, which is why the FDA sets the target for consumer products at less than 2 parts per million. Sunscreen is a particular worry because it is applied broadly, repeatedly and often to children during peak summer months.
Spray formulations add another dimension, because they can be inhaled as well as absorbed through the skin, broadening the routes of exposure. The levels found in some recalled lots, several times the FDA’s target, are what pushed brands toward voluntary recalls and prompted legal action from consumers who argue they were exposed to a known carcinogen through a trusted product.
What consumers can do
Regulators and dermatologists have stressed that the answer is not to stop using sun protection but to switch products. Consumers can check lot numbers against the recall notices, favor mineral formulations built on zinc oxide or titanium dioxide, and return affected items for refunds. Cleveland Clinic guidance notes that the benzene appears to be a manufacturing contaminant rather than an intended ingredient, so brand and batch matter more than sunscreen as a category.
The broader lesson is to weigh a specific, documented contamination against the well-established, everyday risk of skin cancer from unprotected sun exposure. Dermatologists are emphatic that skipping sunscreen is the wrong response; the goal is to choose products not implicated in the recall, particularly mineral-based options, so that protecting against ultraviolet damage does not come with an avoidable chemical exposure.
This article was researched with the help of AI, with human editors creating the final content.
